This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Imris Receives Health Canada Approval For AccuTrack™

WINNIPEG, Aug. 4, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that it has received a Health Canada medical device license for AccuTrack™ the Company's 3D image guidance tool for use in IMRIS neurosurgery suites.

AccuTrack™ represents a significant enhancement to the IMRIS image guided therapy suites. The new software-enabled capability aids surgeons in critical decision making by utilizing an ergonomic lightweight probe to quickly and accurately localize target anatomy before; and at any time during a neurosurgical procedure. This is achieved by enabling automatic registration of patient anatomy to intraoperative MR images, rather than using the standard manual image registration to preoperative MR images which do not accommodate brain shift and may therefore be less accurate.

IMRIS suites are designed to provide timely imaging information to assist clinicians in making better decisions during procedures for improved patient outcomes. The IMRIS system allows a high field MR scanner to move into an operating room on demand before, during and after procedures without moving the patient. The patient is not required to be transported for scanning, thus optimum patient positioning is always maintained. Clinical workflow and access to the patient is not impacted and the MR scanner is removed completely from the operating room when imaging is complete. This ensures a high degree of safety in the surgical environment and for the patient.

AccuTrack™ previously received CE Mark regulatory approval in Europe and is FDA 510(k) Pending in the United States.


IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions. These solutions feature fully integrated surgical and interventional suites that incorporate magnetic resonance, fluoroscopy and computed tomography to deliver on demand imaging during procedures. The Company's systems serve the neurosurgical, cardiovascular and neurovascular markets and have been selected by leading medical institutions around the world.


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs